Other Species / Isoforms
  MRLC2 (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2
______MSSKKAKTK
1 0
MRLC2 (human) ______MSSKKAKTK S2
MRLC2 (mouse) ______MssKKAKTK S2-p
MRLC2 (rat) ______MSSKKAKTK S2
MRLC2 (cow) ______MSSKRAKTK S2
S3
_____MSSKKAKTKT
1 0
MRLC2 (human) _____MSSKKAKTKt S3
MRLC2 (mouse) _____MssKKAKTKT S3-p
MRLC2 (rat) _____MSSKKAKTKT S3
MRLC2 (cow) _____MSSKRAKTKT S3
T10
SKKAKTKTTKKRPQR
0 4
MRLC2 (human) SKKAKTKttKKRPQR T10-p
MRLC2 (mouse) sKKAKTKTTKKRPQR T10
MRLC2 (rat) SKKAKTKTTKKRPQR T10
MRLC2 (cow) SKRAKTKTTKKRPQR T10
T11
KKAKTKTTKKRPQRA
0 6
MRLC2 (human) KKAKTKttKKRPQRA T11-p
MRLC2 (mouse) KKAKTKTTKKRPQRA T11
MRLC2 (rat) KKAKTKTTKKRPQRA T11
MRLC2 (cow) KRAKTKTTKKRPQRA T11
T19-p
KKRPQRAtsNVFAMF
Upstream
Downstream
34 329
Effects on Modified Protein
  • protein conformation
Effects on Biological Processes:
  • exocytosis, altered
Kinase, in vitro:
  • PKACA (cow)
Regulatory protein:
  • PIK3C2A (rat)
Treatment
  • depolarization
  • ionomycin
  • LY294002
  • microcystin-LR
  • norepinephrine
  • peptide inhibitor
  • peptide_agonist
  • staurosporine
  • Y27632
MRLC2 (human) KKRPQRAtsNVFAMF T19-p
MRLC2 (mouse) KKRPQRAtsNVFAMF T19-p
MRLC2 (rat) KKRPQRAtsNVFAMF T19-p
MRLC2 (cow) KKRPQRAtsNVFAMF T19-p
S20-p
KRPQRAtsNVFAMFD
Upstream
Downstream
58 355
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • protein conformation
Effects on Biological Processes:
  • exocytosis, altered
Kinase, in vitro:
  • PKACA (cow)
  • smMLCK (human)
Regulatory protein:
  • PIK3C2A (rat)
Treatment
  • cGMP_analog
  • depolarization
  • dinoprost
  • hypoxia
  • ionomycin
  • LY294002
  • microcystin-LR
  • norepinephrine
  • peptide inhibitor
  • peptide_agonist
  • phorbol_ester
  • staurosporine
  • STO-609
  • SU6656
  • U46619
  • vasopressin
  • Y27632
MRLC2 (human) KRPQRAtsNVFAMFD S20-p
MRLC2 (mouse) KRPQRAtsNVFAMFD S20-p
MRLC2 (rat) KRPQRAtsNVFAMFD S20-p
MRLC2 (cow) KRPQRAtsNVFAMFD S20-p
S29
VFAMFDQSQIQEFKE
0 14
MRLC2 (human) VFAMFDQsQIQEFKE S29-p
MRLC2 (mouse) VFAMFDQsQIQEFKE S29-p
MRLC2 (rat) VFAMFDQSQIQEFKE S29
MRLC2 (cow) VFAMFDQSQIQEFKE S29
K51-ac
NRDGFIDkEDLHDML
0 2
MRLC2 (human) NRDGFIDkEDLHDML K51-ac
MRLC2 (mouse) NRDGFIDKEDLHDML K51
MRLC2 (rat) NRDGFIDkEDLHDML K51-ac
MRLC2 (cow) NRDGFIDKEDLHDML K51
K51
NRDGFIDKEDLHDML
0 6
MRLC2 (human) NRDGFIDkEDLHDML K51-ub
MRLC2 (mouse) NRDGFIDkEDLHDML K51-ub
MRLC2 (rat) NRDGFIDKEDLHDML K51
MRLC2 (cow) NRDGFIDKEDLHDML K51
T97
FGEKLNGTDPEDVIR
0 2
MRLC2 (human) FGEKLNGtDPEDVIR T97-p
MRLC2 (mouse) FGEKLNGTDPEDVIR T97
MRLC2 (rat) FGEKLNGTDPEDVIR T97
MRLC2 (cow) FGEKLNGTDPEDVIR T97
T135
TTMGDRFTDEEVDEL
1 34
MRLC2 (human) TTMGDRFtDEEVDEL T135-p
MRLC2 (mouse) TTMGDRFtDEEVDEL T135-p
MRLC2 (rat) TTMGDRFTDEEVDEL T135
MRLC2 (cow) TTMGDRFTDEEVDEL T135
Y143
DEEVDELYREAPIDK
0 3
MRLC2 (human) DEEVDELyREAPIDk Y143-p
MRLC2 (mouse) DEEVDELYREAPIDk Y143
MRLC2 (rat) DEEVDELYREAPIDK Y143
MRLC2 (cow) DEEVDELYREAPIDK Y143
K150
YREAPIDKKGNFNYI
0 6
MRLC2 (human) yREAPIDkkGNFNyI K150-ub
MRLC2 (mouse) YREAPIDkkGNFNYI K150-ub
MRLC2 (rat) YREAPIDKKGNFNYI K150
MRLC2 (cow) YREAPIDKKGNFNYI K150
K151
REAPIDKKGNFNYIE
0 26
MRLC2 (human) REAPIDkkGNFNyIE K151-ub
MRLC2 (mouse) REAPIDkkGNFNYIE K151-ub
MRLC2 (rat) REAPIDKKGNFNYIE K151
MRLC2 (cow) REAPIDKKGNFNYIE K151
Y156
DKKGNFNYIEFTRIL
0 52
MRLC2 (human) DkkGNFNyIEFTRIL Y156-p
MRLC2 (mouse) DkkGNFNYIEFTRIL Y156
MRLC2 (rat) DKKGNFNYIEFTRIL Y156
MRLC2 (cow) DKKGNFNYIEFTRIL Y156
K164
IEFTRILKHGAKDKD
0 2
MRLC2 (human) IEFTRILkHGAkDKD K164-ub
MRLC2 (mouse) IEFTRILKHGAKDKD K164
MRLC2 (rat) IEFTRILKHGAKDKD K164
MRLC2 (cow) IEFTRILKHGAKDKD K164
K168
RILKHGAKDKDD___
0 1
MRLC2 (human) RILkHGAkDKDD___ K168-ac
MRLC2 (mouse) RILKHGAKDKDD___ K168
MRLC2 (rat) RILKHGAKDKDD___ K168
MRLC2 (cow) RILKHGAKDKDD___ K168